[HTML][HTML] The COVID-19 pandemic and Alzheimer's disease: mutual risks and mechanisms

F Chen, Y Chen, Y Wang, Q Ke, L Cui - Translational neurodegeneration, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19), which is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is a life-threatening disease, especially …

[HTML][HTML] COVID-19 as a Risk Factor for Alzheimer's Disease

M Golzari-Sorkheh, DF Weaver… - Journal of Alzheimer's …, 2023 - content.iospress.com
Severe acute respiratory disease coronavirus 2 (SARS-CoV-2) is responsible for the
coronavirus disease 2019 (COVID-19) pandemic. Although a primarily respiratory disease …

[HTML][HTML] Alzheimer's disease and COVID-19: Interactions, intrinsic linkages, and the role of immunoinflammatory responses in this process

W Li, L Sun, L Yue, S Xiao - Frontiers in immunology, 2023 - frontiersin.org
Alzheimer's disease (AD) and COVID-19 share many common risk factors, such as
advanced age, complications, APOE genotype, etc. Epidemiological studies have also …

Blood-brain barrier penetration of non-replicating SARS-CoV-2 and S1 variants of concern induce neuroinflammation which is accentuated in a mouse model of …

MA Erickson, AF Logsdon, EM Rhea… - Brain, behavior, and …, 2023 - Elsevier
COVID-19 and especially Long COVID are associated with severe CNS symptoms and may
place persons at risk to develop long-term cognitive impairments. Here, we show that two …

[HTML][HTML] Human-derived air–liquid interface cultures decipher Alzheimer's disease–SARS-CoV-2 crosstalk in the olfactory mucosa

MA Shahbaz, S Kuivanen, R Lampinen… - Journal of …, 2023 - Springer
Background The neurological effects of the coronavirus disease of 2019 (COVID-19) raise
concerns about potential long-term consequences, such as an increased risk of Alzheimer's …

[HTML][HTML] COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future

G Amadoro, V Latina, E Stigliano, A Micera - Cells, 2023 - mdpi.com
A growing body of evidence indicates that a neuropathological cross-talk takes place
between the coronavirus disease 2019 (COVID-19)-the pandemic severe pneumonia that …

[HTML][HTML] SARS-CoV-2, long COVID, prion disease and neurodegeneration

Y Zhao, VR Jaber, WJ Lukiw - Frontiers in Neuroscience, 2022 - frontiersin.org
On the last day of the year 2019 a novel Betacoronavirus (2019-nCov), now known as
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and causing the highly …

[HTML][HTML] Molecular mechanisms related to responses to oxidative stress and antioxidative therapies in COVID-19: a systematic review

EE Tsermpini, U Glamočlija, F Ulucan-Karnak… - Antioxidants, 2022 - mdpi.com
The coronavirus disease (COVID-19) pandemic is a leading global health and economic
challenge. What defines the disease's progression is not entirely understood, but there are …

[HTML][HTML] Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes

T Bhardwaj, K Gadhave, SK Kapuganti… - Nature …, 2023 - nature.com
The phenomenon of protein aggregation is associated with a wide range of human
diseases. Our knowledge of the aggregation behaviour of viral proteins, however, is still …

[HTML][HTML] SARS-CoV-2 getting into the brain; neurological phenotype of COVID-19, and management by nano-biotechnology

M Kujawska, E Mostafavi, A Kaushik - Neural Regeneration …, 2023 - journals.lww.com
Human coronavirus infection getting into the brain: By February 2022, the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, causing the coronavirus …